跳至主要内容
临床试验/CTRI/2025/07/090660
CTRI/2025/07/090660已完成不适用

Evaluating the role of salivary miRNA 372 and 486-3p as diagnostic biomarkers in Oral Squamous Cell Carcinoma, precancerous lesions and healthy individuals using qRT-PCR.

未提供1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2025年7月22日最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
80
试验地点
1
主要终点
Identifying biomarkers to understand disease progression

研究概览

简要总结

A double-blind clinical trial has been completed to detect oral premalignancies and cancer at an early stage. The chosen biomarkers for this study were microRNA 372 and 486-3p. Patients who come for routine dental checkups were screened for intra-oral lesions, and saliva samples were collected from them. This study was designed with a sample size of 80, with 20 patients each in Oral cancer, Oral submucous fibrosis, Leukoplakia and controls.

研究设计

研究类型
Observational

入排标准

年龄范围
21.00 Year(s) 至 71.00 Year(s)(—)
性别
All

入选标准

  • Intra-oral lesion or restricted mouth opening Or suspected oral malignancy.

排除标准

  • Those who are unwilling to participate in study Those with other types of cancers.

结局指标

主要结局

Identifying biomarkers to understand disease progression

时间窗: 3 years down the line

次要结局

  • Biomarker based early detection in oral cavity(3 years down the line)

研究者

发起方
未提供
责任方
Principal Investigator
主要研究者

Dr.M.Parasakthi

SRM Dental College

研究点 (1)

Loading locations...

相似试验